Fusion Pharmaceuticals Inc.

Read more
John Valliant's photo - CEO of Fusion Pharmaceuticals Inc.

CEO

John Valliant

CEO Approval Rating

74/100

Founded:

2014

Status:

PublicIndependent CompanyNASDAQFUSN

Annual Revenue
<$1M
Employees
61

FUSION PHARMACEUTICALS INC. TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Fusion Pharmaceuticals Inc.'s company profile
John Valliant's photo - CEO of Fusion Pharmaceuticals Inc.

John Valliant

CEO

74/100
61
$363.5M
$ < 1M
View Profile
1
Fusion Pharmaceuticals Inc.'s Competitor - Athenex logo
Johnson Y.N. Lau's photo - Chairman & CEO of Athenex

Johnson Y.N. Lau

Chairman & CEO

90/100
575
$657.7M
$120.2M
View Profile
2
Fusion Pharmaceuticals Inc.'s Competitor - SpaceOAR logo
CEO Avatar

CEO

- -
140
$46.7M
$13.5M
View Profile
3
Fusion Pharmaceuticals Inc.'s Competitor - ARMO BioSciences logo
Peter Van Vlasselaer's photo - President & CEO of ARMO BioSciences

Peter Van Vlasselaer

President & CEO

93/100
80
$275M
$9M
View Profile
4
Fusion Pharmaceuticals Inc.'s Competitor - NGM Bio logo
David J. Woodhouse's photo - CEO of NGM Bio

David J. Woodhouse

CEO

89/100
210
$344.8M
$81.6M
View Profile
5
Fusion Pharmaceuticals Inc.'s Competitor - vTv Therapeutics logo
Stephen L. Holcombe's photo - President & CEO of vTv Therapeutics

Stephen L. Holcombe

President & CEO

83/100
52
$153.7M
$7.4M
View Profile
6
Fusion Pharmaceuticals Inc.'s Competitor - Lixte logo
John S Kovach's photo - Founder & CEO of Lixte

John S Kovach

Founder & CEO

82/100
3
$10.5M
$ < 1M
View Profile
7
Fusion Pharmaceuticals Inc.'s Competitor - Adicet Bio logo
Chen Schor's photo - President & CEO of Adicet Bio

Chen Schor

President & CEO

87/100
21
$131M
$9.3M
View Profile
8
Fusion Pharmaceuticals Inc.'s Competitor - Alpha-9 logo
Ian McBeath's photo - CEO of Alpha-9

Ian McBeath

CEO

90/100
16
$11M
$1.3M
View Profile
9
Fusion Pharmaceuticals Inc.'s Competitor - Omnitura Therapeutics logo
James Dao's photo - Co-Founder & CEO of Omnitura Therapeutics

James Dao

Co-Founder & CEO

80/100
- -
$12M
View Profile
10
Fusion Pharmaceuticals Inc.'s Competitor - Rheos Medicines logo
Barbara S. Fox's photo - CEO of Rheos Medicines

Barbara S. Fox

CEO

87/100
36
$60M
$1.2M
View Profile
11
Fusion Pharmaceuticals Inc.'s Competitor - Allogene logo
David Chang's photo - President & CEO of Allogene

David Chang

President & CEO

93/100
122
$819.8M
$153.4M
View Profile
12
Fusion Pharmaceuticals Inc.'s Competitor - Mevion logo
Tina Tianning Yu's photo - CEO of Mevion

Tina Tianning Yu

CEO

86/100
225
$500.3M
$12.9M
View Profile

Missing a competitor? Contribute!

Athenex is perceived as one of Fusion Pharmaceuticals Inc.'s biggest rivals. Athenex's headquarters is in Buffalo, New York, and was founded in 2003. Athenex operates in the Biotechnology industry. Athenex generates ∞% of Fusion Pharmaceuticals Inc.'s revenue.

SpaceOAR has been one of Fusion Pharmaceuticals Inc.'s top competitors. SpaceOAR is a Private company that was founded in 2007 in Bedford, Massachusetts. SpaceOAR is in the Health Care Equipment field. Compared to Fusion Pharmaceuticals Inc., SpaceOAR has 79 more employees.

ARMO BioSciences is Fusion Pharmaceuticals Inc.'s #3 rival. ARMO BioSciences was founded in Redwood City, California} in 2012. ARMO BioSciences operates in the Health Care Services industry. Compared to Fusion Pharmaceuticals Inc., ARMO BioSciences generates $9M more revenue.

Fusion Pharmaceuticals Inc. Quarterly and Annual Revenue

Coming soon for Fusion Pharmaceuticals Inc.!

Annual Revenue

Fusion Pharmaceuticals Inc. Acquisitions

No recent acquisitions found related to Fusion Pharmaceuticals Inc.

Fusion Pharmaceuticals Inc. Funding History

Since Fusion Pharmaceuticals Inc. was founded in 2014, it has participated in 4 rounds of funding. In total Fusion Pharmaceuticals Inc. has raised $363.5M. Fusion Pharmaceuticals Inc.'s last funding round was on Jun 2020 for a total of $212.5M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

IPO
Jun 2020
$212.5M
-
Series B
Apr 2019
$105M
Series A
Sep 2017
$21M
Series A
Feb 2017
$25M

Since Fusion Pharmaceuticals Inc. was founded in 2014, it has participated in 4 rounds of funding. In total Fusion Pharmaceuticals Inc. has raised $363.5M. Fusion Pharmaceuticals Inc.'s last funding round was on Jun 2020 for a total of $212.5M

Fusion Pharmaceuticals Inc. Investments

No recent investments found related to Fusion Pharmaceuticals Inc.

Fusion Pharmaceuticals Inc. News

August 10, 2021BioSpace

Fusion Pharmaceuticals Announces Second Quarter 2021 Financial Results and Business Update

Fusion Pharmaceuticals Inc. today announced financial results for the second quarter ended June 30, 2... See more »
July 27, 2021Markets Insider

Fusion Pharmaceuticals Announces FDA Clearance of IND for FPI-1966, an Investigational Radiopharmaceutical for the Treatment of Head and Neck and Bladder Cancers Expressing FGFR3

HAMILTON, ON and BOSTON, July 28, 2021 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a ... See more »
July 7, 2021BioSpace

Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 07, 2021

Fusion Pharmaceuticals Inc. announced that the compensation committee of the Company's Board of Direc... See more »
June 29, 2021RTTNews

Fusion Pharma - Aiming For A Precise Target

Shares of Fusion Pharmaceuticals Inc. (FUSN) have more than halved from their 52-week high of $18.50,... See more »
June 15, 2021Markets Insider

Fusion Pharma Jumps 15%

(RTTNews) - Shares of Fusion Pharmaceuticals Inc. (FUSN) are gaining nearly 15% on Tuesday morning af... See more »
June 14, 2021Markets Insider

Fusion Pharmaceuticals Announces Preliminary Safety and Dosimetry Results from its Single-Dose Portion of the Phase 1 Study of FPI-1434

Product candidate FPI-1434, administered at three different dose levels, demonstrated a favorable saf... See more »
June 9, 2021Manufacturers Monthly

Fusion to build radiopharmaceutical manufacturing facility

Fusion Pharmaceuticals, clinical-stage oncology company that develops radiopharmaceuticals as precisi... See more »

Fusion Pharmaceuticals Inc. Press Releases

December 10, 2020PR Newswire

Fusion Pharmaceuticals Initiates Multi-Dose Portion of Phase 1 Trial of FPI-1434 in Patients with Advanced Solid Tumors

Phase 1 Single-Dose Data Show Uptake Across Multiple Tumor Types; No Dose Limiting Toxicities or Trea... See more »
December 16, 2015PR Newswire

FACIT Announces Investment in Fusion Pharmaceuticals and Alpha-Emitting Radiotherapeutics

Image-guided medicines for hard to treat cancers built using next generation medical isotopes TORONTO... See more »

Social Media

Fusion Pharmaceuticals Inc. Headquarters

270 Longwood Road South

Hamilton, OntarioL8P 0A6

1-289-799-0891

Driving Directions »

Trending Companies

Fusion Pharmaceuticals Inc. Summary

ABOUT

Overview

Fusion Pharma develops and commercializes targeted alpha-particle radiotherapeutics for the treatment of cancer. Fusion Pharmaceuticals Inc. was founded in 2014. Fusion Pharmaceuticals Inc.'s headquarters is located in Hamilton, Ontario, CA L8P 0A6. I...

CEO

Fusion Pharmaceuticals Inc.'s CEO, John Valliant, currently has an approval rating of 74%. Fusion Pharmaceuticals Inc.'s primary competitors are Athenex, SpaceOAR & ARMO BioSciences.

Frequently Asked Questions about Fusion Pharmaceuticals Inc.

  1. When was Fusion Pharmaceuticals Inc. founded?

    Fusion Pharmaceuticals Inc. was founded in 2014
  2. Who is Fusion Pharmaceuticals Inc.'s CEO?

    Fusion Pharmaceuticals Inc.'s CEO is John Valliant
  3. How much revenue does Fusion Pharmaceuticals Inc. generate?

    Fusion Pharmaceuticals Inc. generates $ < 1M in revenue
  4. How much funding does Fusion Pharmaceuticals Inc. have?

    Fusion Pharmaceuticals Inc. has historically raised $363.5M in funding
  1. Where is Fusion Pharmaceuticals Inc.'s headquarters?

    Fusion Pharmaceuticals Inc.'s headquarters is in Hamilton Ontario, CA
  2. How many employees does Fusion Pharmaceuticals Inc. have?

    Fusion Pharmaceuticals Inc. has 61 employees
  3. What sector does Fusion Pharmaceuticals Inc. operate in?

    Fusion Pharmaceuticals Inc. is in Pharmaceuticals
  4. Who are Fusion Pharmaceuticals Inc.'s competitors?

    Fusion Pharmaceuticals Inc.'s top competitors are Athenex, SpaceOAR, ARMO BioSciences